LSB
Price
$0.77
Change
-$0.00 (-0.00%)
Updated
Sep 19, 10:29 AM (EDT)
TVGN
Price
$0.45
Change
+$0.02 (+4.65%)
Updated
Sep 19, 10:51 AM (EDT)
Ad is loading...

LSB vs TVGN

Header iconLSB vs TVGN Comparison
Open Charts LSB vs TVGNBanner chart's image
LakeShore Biopharma
Price$0.77
Change-$0.00 (-0.00%)
Volume$945
CapitalizationN/A
Tevogen Bio Holdings
Price$0.45
Change+$0.02 (+4.65%)
Volume$3K
CapitalizationN/A
View a ticker or compare two or three
LSB vs TVGN Comparison Chart
Loading...
LSB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TVGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
LSB vs. TVGN commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSB is a StrongBuy and TVGN is a Buy.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (LSB: $0.77 vs. TVGN: $0.44)
Brand notoriety: LSB and TVGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LSB: 415% vs. TVGN: 13%
Market capitalization -- LSB: $147.34M vs. TVGN: $74.73M
LSB [@Biotechnology] is valued at $147.34M. TVGN’s [@Biotechnology] market capitalization is $74.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $599.73B to $0. The average market capitalization across the [@Biotechnology] industry is $3.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LSB’s FA Score shows that 1 FA rating(s) are green whileTVGN’s FA Score has 1 green FA rating(s).

  • LSB’s FA Score: 1 green, 4 red.
  • TVGN’s FA Score: 1 green, 4 red.
According to our system of comparison, LSB is a better buy in the long-term than TVGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LSB’s TA Score shows that 5 TA indicator(s) are bullish while TVGN’s TA Score has 4 bullish TA indicator(s).

  • LSB’s TA Score: 5 bullish, 4 bearish.
  • TVGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, LSB is a better buy in the short-term than TVGN.

Price Growth

LSB (@Biotechnology) experienced а +41.79% price change this week, while TVGN (@Biotechnology) price change was -0.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +7.58%, and the average quarterly price growth was +1.88%.

Reported Earning Dates

TVGN is expected to report earnings on Apr 17, 2023.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LSB($147M) has a higher market cap than TVGN($74.7M). LSB YTD gains are higher at: 51.115 vs. TVGN (-96.066).
LSBTVGNLSB / TVGN
Capitalization147M74.7M197%
EBITDAN/A-33.42M-
Gain YTD51.115-96.066-53%
P/E RatioN/A7.58-
RevenueN/A0-
Total CashN/A1.14M-
Total DebtN/A2.02M-
TECHNICAL ANALYSIS
Technical Analysis
LSBTVGN
RSI
ODDS (%)
Bearish Trend 1 day ago
36%
Bullish Trend 1 day ago
44%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
31%
Bullish Trend 1 day ago
41%
Momentum
ODDS (%)
Bullish Trend 1 day ago
45%
Bearish Trend 1 day ago
36%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
32%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
46%
Bearish Trend 1 day ago
49%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
41%
Bearish Trend 1 day ago
58%
Advances
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 21 days ago
42%
Declines
ODDS (%)
Bearish Trend 14 days ago
82%
Bearish Trend 1 day ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
32%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
30%
Bearish Trend 1 day ago
71%
View a ticker or compare two or three
Ad is loading...
LSB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TVGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMBUX13.770.01
+0.07%
MassMutual Select TRP Sm&Mid Cap Blend I
FCCVX33.78-0.03
-0.09%
Fidelity Advisor Convertible Secs C
FSEWX12.90-0.02
-0.15%
Fidelity Sustainable U.S. Eq Z
MSFHX20.59-0.06
-0.29%
MFS Total Return R3
FTUTX52.21-0.24
-0.46%
Fidelity Advisor Telecommunications M

LSB and

Correlation & Price change

A.I.dvisor tells us that LSB and SKYE have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LSB and SKYE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSB
1D Price
Change %
LSB100%
-2.39%
SKYE - LSB
21%
Poorly correlated
-0.57%
SONN - LSB
20%
Poorly correlated
+1.52%
BYSI - LSB
20%
Poorly correlated
-3.61%
ATYR - LSB
12%
Poorly correlated
-0.54%
TVGN - LSB
7%
Poorly correlated
-2.73%
More

TVGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVGN has been loosely correlated with TNFA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if TVGN jumps, then TNFA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVGN
1D Price
Change %
TVGN100%
-2.73%
TNFA - TVGN
52%
Loosely correlated
-4.68%
SCPX - TVGN
28%
Poorly correlated
+2.37%
COGT - TVGN
26%
Poorly correlated
+0.19%
GLSI - TVGN
22%
Poorly correlated
-0.28%
HEPA - TVGN
22%
Poorly correlated
-5.42%
More